# A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics

> **NCT02345356** · — · COMPLETED · sponsor: **University of Puerto Rico** · enrollment: 200 (actual)

## Conditions studied

- Atrial Fibrillation
- Deep Vein Thrombosis
- Cardiac Valvular Insufficiency
- Coagulopathies
- Pulmonary Embolism

## Interventions

- **GENETIC:** Genotype-guided
- **OTHER:** Standard-of-Care

## Key facts

- **NCT ID:** NCT02345356
- **Lead sponsor:** University of Puerto Rico
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2022-05-17
- **Final completion:** 2022-05-17
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2022-05-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02345356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02345356, "A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02345356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*